EDSA Edesa Biotech, Inc.
Healthcare$9.70-7.27%ClosedMarket Cap: $86.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
8.47
P/S
0.00
EV/EBITDA
-7.92
DCF Value
$2.00
FCF Yield
-8.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-82.3%
ROA
-84.3%
ROIC
-108.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $0.00 | -Infinity% | $-4.3M | $-4.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.3M | $-2.2M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.5M | $-2.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-7.9M | $-7.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.9M | $-1.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.6M | $-1.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.9M | $-1.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-1.0M | $-962.1K | $— | — |
| FY null | $0.00 | -Infinity% | $-7.0M | $-6.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.9M | $-1.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.2M | $-1.9M | $— | — |
| Q1 2024 | $0.00 | -Infinity% | $-1.9M | $-1.7M | $-0.54 | — |